Rezultat publicatTED — Licitații europene73000000 — Servicii de cercetare si de dezvoltare si servicii conexe de consultanta·657135-2026
Norvegia – Servicii de cercetare şi de dezvoltare şi servicii conexe de consultanţă – Development services for minimally invasive glaucoma surgery (MIGS) device
Anunțul 657135-2026 pentru Norvegia – Servicii de cercetare şi de dezvoltare şi servicii conexe de consultanţă – Development services for minimally invasive glaucoma surgery (MIGS) device este publicat de Inven2 AS și este încadrat la codul CPV 73000000.
Sinteză HarveyAI
Harvey procesează documentele acestei licitații...
In the original tender, the two qualified providers did not fully comply with the requirements, one delivering after the deadline and one neglecting to include subproviders.
Dispatch date
2026-09-23Z
Dispatch time
07:57:01.873Z
Official language
ENG
Ojs number
185/2026
Received submissions type code
Loc de executare5
Place of performance
NO081 | NOR | NO081 | NOR
Place of performance country LOT
NOR
Place of performance country PROC
NOR
Place of performance subdiv LOT
NO081
Place of performance subdiv PROC
NO081
Câștigători și oferte8
Winner city
Glasgow
Winner country
GBR
Winner identifier
SC285921
Winner internet address
https://www.fearsome.co.uk
Winner name
Fearsome Ltd
Winner post code
G4 9SS
Winner selection status
selec-w
Winner size
sme
Loturi6
Additional classification LOT
33000000 | 33122000
Additional classification type LOT
cpv | cpv
Eu fund LOT
no-eu-funds
Identifier LOT
LOT-0001
Renewal description LOT
Three years. The contract may be extended by another 3 years, pending the availability of development funding. While the present contract seeks to develop a device that can be tested in vivo (prototype), the option refers to development of a device suitable for clinical testing. This entails the use of clinical-grade materials, risk planning, and regulatory development as well as preparation of the clinical trial. We foresee the delivery of clinical-grade stents in batches of 30-100. The option may be called within 3 years following the completion of the initial project.
Renewal maximum LOT
1
Termene și durate2
Duration period unit LOT
MONTH
Duration period value LOT
60
Procedură și anunț4
Legal basis
32014L0024
Legal basis NOTICE
32014L0024
Procedure identifier
e42c1ba2-bf6c-4de9-b1f9-6aed5fa1a69b
Procedure type
neg-wo-call
Clasificare CPV2
Main classification type LOT
cpv
Main classification type PROC
cpv
Valori2
Total value
3000000
Total value CUR
NOK
Date de contact publicate în TED
17
Contactele sunt disponibile utilizatorilor autentificați.Autentifică-te
Textul integral publicat de TEDextinde
Oslo tingrett
In the original tender, the two qualified providers did not fully comply with the requirements, one delivering after the deadline and one neglecting to include subproviders.
Development services for minimally invasive glaucoma surgery (MIGS) device
Fearsome Ltd
Price
Quality of Technical Solution
Project Management and Delivery Capability
Inven2 AS
Three years. The contract may be extended by another 3 years, pending the availability of development funding. While the present contract seeks to develop a device that can be tested in vivo (prototype), the option refers to development of a device suitable for clinical testing. This entails the use of clinical-grade materials, risk planning, and regulatory development as well as preparation of the clinical trial. We foresee the delivery of clinical-grade stents in batches of 30-100. The option may be called within 3 years following the completion of the initial project.
Artifik AS
We are seeking quotes for the development and manufacturing of a multi-lumen stent intended for minimally invasive glaucoma surgery (MIGS). The device is designed to lower intraocular pressure (IOP), a key factor in the progression of glaucoma, with the ability to regulate pressure post insertion. The development scope, estimated to about 2 years of development, includes optimising the stent design using in sil billiard modelling, prototyping, and in vitro testing with ocular models and extracted pig eyes. Manufacturing will involve precision techniques such as microscale injection moulding and extrusion, ensuring the production of a batch that meets the standards for preclinical testing. Approximately 100 units are planned for manufacturing to support the initial in vitro testing and a preclinical efficacy study in pigs.
[email eliminat]
01
2026-06-12Z
neg-wo-call
selec-w
2026-09-24+02:00
https://www.inven2.com
Glasgow
none
33122000
0125
G4 9SS
[telefon eliminat]/2026
price
ORG-0003
ORG-0004
Eirik Torheim
t-esubm
2026-09-18Z
The Whisky Bond, 2 Dawson Road
ORG-[telefon eliminat]
Gaustadalléen 21
ORG-0002
gen-pub
Oslo
Stortingsgata 12
NO081
CON-0001
[email eliminat]
NOK
no-eu-funds
quality
NOR
32014L0024
1
per-exa
https://www.domstol.no/no/domstoler/tingrett/oslo-tingrett/
can-standard
SC285921
60
Postboks 2106 Vika
7726
33[telefon eliminat]
ENG
[email eliminat]
7385
no
body-pl
5682
[telefon eliminat]Z
29
[email eliminat]
TEN-0001
sme
irregular
eforms-sdk-1.13
e42c1ba2-bf6c-4de9-b1f9-6aed5fa1a69b
RES-0001
LOT-0001
https://artifik.no
GBR
TPA-0001
0349
https://www.fearsome.co.uk
995495899
925364967
9532
[telefon eliminat]
serv-prov
false
01 ••• ••• 05-a160-4bee-8396-70ffcde159c2
services
07:57:01.873Z
[telefon eliminat]
Loturi TED
1
7385
Development services for minimally invasive glaucoma surgery (MIGS) device
We are seeking quotes for the development and manufacturing of a multi-lumen stent intended for minimally invasive glaucoma surgery (MIGS). The device is designed to lower intraocular pressure (IOP), a key factor in the progression of glaucoma, with the ability to regulate pressure post insertion. The development scope, estimated to about 2 years of development, includes optimising the stent design using in sil billiard modelling, prototyping, and in vitro testing with ocular models and extracted pig eyes. Manufacturing will involve precision techniques such as microscale injection moulding and extrusion, ensuring the production of a batch that meets the standards for preclinical testing. Approximately 100 units are planned for manufacturing to support the initial in vitro testing and a preclinical efficacy study in pigs.
73000000 — Servicii de cercetare si de dezvoltare si servicii conexe de consultanta
Durată: 60 MONTH
Rezultate și atribuiri TED
LOT-00013.000.000,00 NOK
Câștigător: Fearsome Ltd · CUI SC285921
Contract 953218 sept. 2026
Detalii licitație
Descriere
We are seeking quotes for the development and manufacturing of a multi-lumen stent intended for minimally invasive glaucoma surgery (MIGS). The device is designed to lower intraocular pressure (IOP), a key factor in the progression of glaucoma, with the ability to regulate pressure post insertion. The development scope, estimated to about 2 years of development, includes optimising the stent design using in sil billiard modelling, prototyping, and in vitro testing with ocular models and extracted pig eyes. Manufacturing will involve precision techniques such as microscale injection moulding and extrusion, ensuring the production of a batch that meets the standards for preclinical testing. Approximately 100 units are planned for manufacturing to support the initial in vitro testing and a preclinical efficacy study in pigs.
Căutări relevante pentru 657135-2026
Legături interne utile pentru CPV, autoritate și expresiile principale din denumirea procedurii.